Preconception Management for Women with History of Gestational Diabetes, Hypothyroidism, and Hypertension

Immediate Blood Pressure Management

The American College of Cardiology recommends targeting blood pressure at 110-135/85 mmHg during pregnancy to minimize both maternal complications and impairment of fetal growth 1
Target blood pressure should be below 140/90 mmHg but not below 80 mmHg diastolic to balance maternal cardiovascular protection with adequate uteroplacental perfusion 1
Extended-release nifedipine should be started as first-line therapy for women planning pregnancy, with the strongest safety data and once-daily dosing to improve adherence 1
Alternative options include labetalol or methyldopa, with the longest safety record, though use cautiously if depression risk exists 1

Copper IUD is the optimal choice as a Category 1 option for women with poorly controlled hypertension, with less than 1% failure rate and no hormonal effects on blood pressure or glucose metabolism 2
Combined hormonal contraceptives are absolutely contraindicated in women with systolic blood pressure ≥140 mmHg or diastolic ≥90 mmHg combined with vascular disease history, as ischemic stroke risk increases 8-15 fold 2

Women planning pregnancy should stop statins 1-2 months before attempting conception due to the risk of fetal malformations, including severe central nervous system defects 3
Aggressive lifestyle intervention takes priority over pharmacological lipid management during the preconception period, with a focus on reducing LDL and total cholesterol levels 3

Ideally, TSH should be less than 2.5 mIU/L before conception for women with a history of gestational hypothyroidism, though guidelines vary 4
Recheck TSH and consider restarting levothyroxine if TSH rises above 2.5 mIU/L during the preconception period 4

Check HbA1c now, with a target of less than 6.5% (48 mmol/mol) before conception, and ideally less than 6% if achievable without hypoglycemia 4
Fasting glucose and 2-hour 75g OGTT should be performed to rule out progression to type 2 diabetes 4

Start low-dose aspirin 75-150 mg daily at bedtime immediately, either pre-pregnancy or upon pregnancy confirmation, but before 16 weeks gestation, to reduce preeclampsia risk 1
Her history of gestational hypertension confers a 25% risk of developing superimposed preeclampsia in subsequent pregnancy 1

Baseline assessments required before conception include complete blood count, liver enzymes, serum creatinine, electrolytes, uric acid, and urine protein-to-creatinine ratio or 24-hour urine protein 1
Comprehensive ophthalmologic exam to assess for hypertensive or diabetic retinopathy, and ECG given age over 35 years with cardiac risk factors 4

Folic acid 400 mcg daily, sodium restriction to 2.4 g daily, and low to moderate-intensity exercise in consultation with an obstetrician to reduce gestational hypertension and preeclampsia risk 1
Weight optimization if BMI is elevated, though weight reduction should not be attempted during pregnancy itself 1

Confirm hypertension diagnosis with home blood pressure monitoring or 24-hour ambulatory monitoring before long-term treatment, as up to 25% of elevated clinic readings represent white-coat hypertension 1
Blood pressure monitoring at least every 2 weeks until control is achieved, then monthly, and repeat HbA1c every 3 months if diabetes is confirmed 2

Do not discontinue contraception until blood pressure is consistently below 140/90 mmHg on pregnancy-safe antihypertensive for at least 1-2 months, HbA1c is less than 6.5% if diabetes is present, TSH is optimized to less than 2.5 mIU/L, low-dose aspirin is initiated, and all teratogenic medications are discontinued 1

Annual cardiovascular risk assessment is required lifelong after pregnancy with hypertensive disorders, with aggressive management of modifiable risk factors (hypertension, hyperlipidemia, glucose control) essential for long-term health 1